ロード中...
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
BACKGROUND: We investigated the potential associations between cerebro-spinal fluid (CSF) levels of phosphorylated tau (P-tau) and total tau (T-tau) with short-term response to cholinesterase inhibitor (ChEI) treatment, longitudinal outcome and progression rates in Alzheimer’s disease (AD). METHODS:...
保存先:
| 出版年: | BMC Neurol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6951013/ https://ncbi.nlm.nih.gov/pubmed/31918679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-019-1591-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|